+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Experimental models in drug development for helminthic diseases

Experimental models in drug development for helminthic diseases

Reviews of Infectious Diseases 11(4): 638-654

The prevalence and socioeconomic impact of helminthic infections continue to be of global concern, particularly in areas with tropical climates, poor sanitation, low standards of living, and poor health education. Considerable progress has been achieved in the development of anthelmintics, and a number of useful model systems are available. The uses and pharmacologic and clinical features of a number of anthelmintics are reviewed.

(PDF emailed within 0-6 h: $19.90)

Accession: 001831875

Download citation: RISBibTeXText

PMID: 2672241

DOI: 10.1093/clinids/11.4.638

Related references

Investigation of imported helminthic diseases part 2 intensity of invasions with intestinal helminthic diseases. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 43(2): 146-149, 1974

Study of the anti helminthic activity of benzimidazole derivatives part 1 methyl ether of benzimidazole 2 carbamine acid and other derivatives of 2 amino benzimidazole in experimental helminthic diseases of laboratory animals. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 39(4): 427-429, 1970

Experimental studies on anti helminthic effect of drugs 2. anti helminthic effect against the larval parasites of different development stages. Bulletin of Azabu University Veterinary Medicine 1(1): 131-144, 1980

Current drug targets for helminthic diseases. Parasitology Research 112(5): 1819-1831, 2013

Experimental study on the anti helminthic drug tetramisole. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 40(4): 414-419, 1971

Experimental study of a new anti helminthic drug jonite. Meditsinskaya Parazitologiya I Parazitarnye Bolezni: 311-314, 1974

On helminthic fauna and prevalence of helminthic diseases among the population of the Leningrad region. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 38(2): 138-141, 1969

Animal models of hyperfunctioning parathyroid diseases for drug development. Expert Opinion on Drug Discovery 4(7): 727-740, 2009

In vivo models of cardiac diseases: application to drug development and screening. Expert Opinion on Drug Discovery 5(1): 65-78, 2010

Three-dimensional culture models for human viral diseases and antiviral drug development. Antiviral Research 71(2-3): 96-107, 2006

Increased number of mast cells and helminthic diseases. Experimental mastocytosis in mice. Acta Tropica 19: 248-251, 1962

Human experimental pain models: A review of standardized methods in drug development. Journal of Research in Medical Sciences 17(6): 587-595, 2013

In vitro and in vivo experimental models for drug screening and development for Chagas disease. Memorias do Instituto Oswaldo Cruz 105(2): 233-238, 2010

Climate and development of helminths. II. Climatology and epidemiology of helminthic diseases. 1972

Progressive development in experimental models of transungual drug delivery of anti-fungal agents. International Journal of Cosmetic Science 38(1): 1-12, 2016